SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : OXIGENE INC. (OXGN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: dalroi who wrote (196)2/4/2001 10:41:08 PM
From: keokalani'nui  Read Replies (1) of 273
 
Bioorg Med Chem Lett 2001 Jan 8;11(1):51-4 Related Articles, Books

Antimitotic and cell growth inhibitory properties of combretastatin A-4-like ethers.

Lawrence NJ, Rennison D, Woo M, McGown AT, Hadfield JA

Department of Chemistry, UMIST, Manchester, UK. lawrencenj1@cardiff.ac.uk

[Medline record in process]

A series of diarylamines, diaryl and arylbenzyl ethers based on combretastatin A-4 was prepared and evaluated for anticancer activity. 2-Methoxy-5-(3',4',5'-trimethoxyphenoxymethyl)phenol was the most active (IC50, K562 20 nM) and caused significant G2/M cell cycle arrest.

PMID: 11140732
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext